Aurobindo Pharma Ltd — Lisinopril Exporter Profile
Indian Pharmaceutical Exporter · #7 for Lisinopril · $1.7M export value · DGFT Verified
Aurobindo Pharma Ltd is the #7 Indian exporter of Lisinopril with $1.7M in export value and 183 verified shipments. Aurobindo Pharma Ltd holds a 2.9% market share in Lisinopril exports across 9 countries.
Aurobindo Pharma Ltd — Lisinopril Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Lisinopril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $1.0M | 128 | 60.1% |
| CANADA | $173.9K | 23 | 10.0% |
| UNITED KINGDOM | $132.9K | 9 | 7.6% |
| FINLAND | $119.8K | 6 | 6.9% |
| VIETNAM, DEMOCRATIC REP. OF | $104.6K | 5 | 6.0% |
| MEXICO | $50.0K | 1 | 2.9% |
| TANZANIA | $39.9K | 5 | 2.3% |
| VIETNAM | $34.7K | 1 | 2.0% |
| ETHIOPIA | $23.5K | 7 | 1.4% |
| NETHERLANDS | $15.1K | 4 | 0.9% |
Aurobindo Pharma Ltd exports Lisinopril to 11 countries. The largest destination is MALTA accounting for 60.1% of Aurobindo Pharma Ltd's Lisinopril shipments, followed by CANADA (10.0%) and UNITED KINGDOM (7.6%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lisinopril from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $532.8K | 67 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $501.7K | 52 |
| AURO PHARMA INC | CANADA | $136.2K | 15 |
| MILPHARM LIMITED | UNITED KINGDOM | $132.9K | 9 |
| ORION CORPORATION | FINLAND | $75.9K | 3 |
| DA NANG PHAMACEUTICAL- MEDICAL | VIETNAM, DEMOCRATIC REP. OF | $50.6K | 3 |
| AUROVIDA FARMACEUTICA S.A DE C.V | MEXICO | $50.0K | 1 |
| DA NANG PHARMACEUTICAL- | VIETNAM, DEMOCRATIC REP. OF | $38.4K | 1 |
| DANANG PHARMACEUTICAL-MEDICAL | VIETNAM | $34.7K | 1 |
| ORION CORPORATION, | FINLAND | $33.2K | 2 |
Aurobindo Pharma Ltd supplies Lisinopril to 28 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by APL SWIFT SERVICES MALTA LTD (MALTA) and AURO PHARMA INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lisinopril Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $15.9M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. Aurobindo Pharma Ltd contributes $1.7M to this total, accounting for 2.9% of India's Lisinopril exports. Aurobindo Pharma Ltd ships Lisinopril to 11 countries through 28 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Lisinopril Exports?
Aurobindo Pharma Ltd's average Lisinopril shipment value is $9.6K per consignment, based on 183 shipments totaling $1.7M. The largest destination is MALTA (60.1% of Aurobindo Pharma Ltd's Lisinopril exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Lisinopril Exporters?
Aurobindo Pharma Ltd ranks #7 among 221 Indian Lisinopril exporters with a 2.9% market share. The top 3 exporters are LUPIN LIMITED ($4.3M), IPCA LABORATORIES LIMITED ($2.7M), MICRO LABS LIMITED ($1.9M). Aurobindo Pharma Ltd processed 183 shipments to 9 destination countries.
What Lisinopril Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LISINOPRIL 5MG (Lisinopril Aurobindo 5 m | $241.4K | 22 |
| LISINOPRIL TABLETS 20MG (Lisinopril Auro | $111.3K | 11 |
| LISINOPRIL TABLETS 10MG(LISINOPRIL AUROB | $106.5K | 4 |
| LISINOPRIL TABLETS 10MG (Lisinopril Auro | $78.9K | 5 |
| LISINOPRIL TABLETS 10MG(Lisinopril 10 mg | $73.4K | 4 |
| LISINOPRIL TABLETS 20MG (AURO-LISINOPRIL | $55.8K | 9 |
| LISINOPRIL TABLETS 10MG (AURO-LISINOPRIL | $50.9K | 6 |
| LISINOPRIL TABLETS 30MG (AUROLIZA 30) 2X14'S (74086 PACK)NOS | $50.6K | 3 |
| LISINOPRIL TABLETS 10MG(LISINOPRIL TABLE | $50.0K | 1 |
| LISINOPRIL HYDROCHLOROTHIAZIDE TABLETS 10-12.5 MG/ 67869 PACKS OF 2X14'S(AS PERINVOICE) | $38.4K | 1 |
Aurobindo Pharma Ltd exports 109 distinct Lisinopril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LISINOPRIL 5MG (Lisinopril Aurobindo 5 m with 22 shipments worth $241.4K.
Regulatory Requirements: Exporting Lisinopril to Key Markets
What Aurobindo Pharma Ltd must comply with to export Lisinopril to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Lisinopril Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | IPCA LABORATORIES LIMITED | $2.7M | 418 | 10 | $6.4K |
| 4 | MICRO LABS LIMITED | $1.9M | 50 | 5 | $38.7K |
| 7 | AUROBINDO PHARMA LTD ★ | $1.7M | 183 | 9 | $9.6K |
| 8 | MARKSANS PHARMA LIMITED | $936.1K | 47 | 1 | $19.9K |
| 1 | MYLAN LABORATORIES LIMITED | $800.0K | 16 | 1 | $50.0K |
Aurobindo Pharma Ltd ranks #7 among 221 Indian Lisinopril exporters. Average shipment value of $9.6K compared to the market average of $72.1K. The closest competitors by value are IPCA LABORATORIES LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Lisinopril Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 597 | 17.0% |
| DELHI AIR CARGO ACC (INDEL4) | 514 | 14.6% |
| SAHAR AIR | 509 | 14.5% |
| DELHI AIR | 282 | 8.0% |
| NHAVA SHEVA SEA (INNSA1) | 238 | 6.8% |
| Bombay Air | 172 | 4.9% |
| HYDERABAD ICD (INSNF6) | 112 | 3.2% |
| Delhi Air | 110 | 3.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 192 individual customs records matching Aurobindo Pharma Ltd exporting Lisinopril, covering 109 formulations to 11 countries via 28 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lisinopril Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Lisinopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Lisinopril Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current shipment-level data, contact TransData Nexus.